All Pharma News
price-trendAsk Us
Delsitech Announces a Major Licensing Agreement on Drug Delivery

Delsitech Announces a Major Licensing Agreement on Drug Delivery
PR NEWSWIRE
23 May 2024
Share Share
DelSiTech and Tolmar Announce Global License and Development Agreement

DelSiTech and Tolmar Announce Global License and Development Agreement
PR NEWSWIRE
13 Feb 2024
Share Share
DelSiTech Announces Closing of EUR 10 Million Financing Round

DelSiTech Announces Closing of EUR 10 Million Financing Round
PR NEWSWIRE
16 Jan 2024
Share Share
DelSiTech announces +ve topline datafrom ph1 trial with its SR eye drop platform

DelSiTech announces +ve topline datafrom ph1 trial with its SR eye drop platform
PR NEWSWIRE
29 Jun 2023
Share Share
DelSiTech Awarded a Grant to Develop Injectables for Prophylactic HIV Vaccine

DelSiTech Awarded a Grant to Develop Injectables for Prophylactic HIV Vaccine
PR NEWSWIRE
15 Mar 2023
Share Share
Iveric granted rights to commercialise formulations of AMD treatment

Iveric granted rights to commercialise formulations of AMD treatment
PMM
15 Jul 2022
Share Share
Iveric to develop sustained-release form of retinal disease drug

Iveric to develop sustained-release form of retinal disease drug
Nick Paul Taylor FIERCEPHARMA
05 Jul 2022
Share Share
Optifye and DelSiTech partner on controlled-release eye drops

Optifye and DelSiTech partner on controlled-release eye drops
N.P. Taylor FIERCEPHARMA
30 Mar 2022
Share Share
DelSiTech Enters into an Exclusive Licensing Agreement with Optifye Therapeutics

DelSiTech Enters into an Exclusive Licensing Agreement with Optifye Therapeutics
PRNEWSWIRE
28 Mar 2022
Share Share
DelSiTech receives funding from Bill & Melinda Gates Foundation for injectables

DelSiTech receives funding from Bill & Melinda Gates Foundation for injectables
PHARMABIZ
21 May 2019
Share Share